Sign in

Trial result ·

Effect of Age and Age-Defined Menopausal Status on Linaclotide Efficacy and Safety in Adults With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation: Post Hoc Analyses of Phase 2b/3 Studies.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This study looked at the drug linaclotide in adults with IBS-C or CIC. Both conditions involve constipation. The team pooled data from earlier trials. In each trial, people were put into groups by chance. Some got linaclotide, and others got a dummy drug called placebo. People were split by age: under 65, or 65 and over. Women were also split by age as a stand-in for menopause. Those 45 or under counted as before menopause, and over 45 as after. This was a fresh look at old data, done after the trials ended.

What they found

Linaclotide raised the number of full bowel movements each week more than placebo. This held in both age groups and both menopause groups. In IBS-C, people 65 and over gained 2.6 per week on 290 μg. In that same age group, placebo gave a gain of 0.9. Belly symptoms also eased more with linaclotide in every group. The typical time to improve was shorter with linaclotide than with placebo. Safety was in line with past studies.

What it means for patients

The authors say age did not seem to change how well linaclotide worked. Menopause status, judged by age, did not seem to change it either. Bowel and belly symptoms got better in all of these groups. The authors say the drug may work in a similar way across them.

Why it is not certain yet

The authors call this an exploratory look done after the trials. The trials were not first set up to answer this question. Menopause was judged by age alone, not confirmed by doctors. The abstract does not give how many people were in each group. The authors describe the results as links, not firm proof.

Source

Effect of Age and Age-Defined Menopausal Status on Linaclotide Efficacy and Safety in Adults With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation: Post Hoc Analyses of Phase 2b/3 Studies.

PubMed · PMID 42702764

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Irritable bowel syndrome publications